NCT00486785View on ClinicalTrials.gov

SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

PHASE4CompletedINTERVENTIONAL

Enrollment

431

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2008

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Alfuzosin

Alfuzosin 10mg Once Daily for 24 weeks

Trial Locations (4)

Unknown

Sanofi-Aventis, Bogotá

Sanofi-Aventis, Quito

Sanofi-Aventis, Guatemala City

Sanofi-Aventis, México

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY